Clinical Trial Update: A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing fulvestrant regimens in advanced/metastatic breast cancer has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-08-29